Krystal Biotech Inc (KRYS)

SG&A Expense Growth

29.08%

Fiscal year · Period ending:

KRYS logo

KRYS SG&A Expense Growth

Latest reported29.08%
KRYS FY SG&A Growth (YoY) (0.00% → 29.08%)
High-resolution chart · PNG

KRYS sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Krystal Biotech Inc SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
29.0757%
15.5334%
26.5852%
92.4562%
205.7145%
104.3619%
55.5957%
165.665%
289.0547%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.